SR One

SR One is one of the longest-standing life sciences venture capital firms, originally founded as the venture arm of GlaxoSmithKline. Now operating as an independent firm, SR One invests globally in innovative biopharmaceutical companies developing breakthrough therapies across therapeutic areas.